Eurojust, the European Union’s judicial cooperation unit, and the EMCDDA, have released today their first joint publication entitled New psychoactive substances in Europe. Legislation and prosecution — current challenges and solutions.
The rapid evolution of the European market for new psychoactive substances (NPS) has challenged national authorities to find suitable and efficient responses to the public health and judicial problems caused by these substances. The legal issues surrounding the control of new substances are complex, and this publication examines different control mechanisms and their implications.
